| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.73e-05 | 1356 | 30 | 10 | GO:0060090 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.44e-05 | 1160 | 30 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 6.08e-05 | 8 | 30 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 9.75e-05 | 10 | 30 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.65e-04 | 229 | 30 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.08e-04 | 20 | 30 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.50e-04 | 21 | 30 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.04e-03 | 303 | 30 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.12e-03 | 33 | 30 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.38e-03 | 562 | 30 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.81e-03 | 42 | 30 | 2 | GO:0005109 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.98e-03 | 44 | 30 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.66e-03 | 51 | 30 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.72e-03 | 187 | 30 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.08e-03 | 55 | 30 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.66e-03 | 60 | 30 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 4.15e-03 | 64 | 30 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.52e-03 | 739 | 30 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.67e-03 | 68 | 30 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.81e-03 | 69 | 30 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.90e-03 | 753 | 30 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 5.08e-03 | 71 | 30 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.10e-03 | 78 | 30 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 9.40e-03 | 560 | 30 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 9.75e-03 | 566 | 30 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.02e-02 | 102 | 30 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.04e-02 | 103 | 30 | 2 | GO:0008276 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.06e-02 | 104 | 30 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.08e-02 | 105 | 30 | 2 | GO:0008170 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.40e-02 | 120 | 30 | 2 | GO:0008013 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 8.89e-06 | 358 | 29 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 8.89e-06 | 358 | 29 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 9.47e-06 | 362 | 29 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.15e-05 | 1390 | 29 | 10 | GO:0045944 | |
| GeneOntologyBiologicalProcess | mRNA cis splicing, via spliceosome | 3.89e-05 | 47 | 29 | 3 | GO:0045292 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 5.27e-05 | 52 | 29 | 3 | GO:0006376 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection arborization | 5.32e-05 | 8 | 29 | 2 | GO:0150012 | |
| GeneOntologyBiologicalProcess | RNA splicing | 5.95e-05 | 502 | 29 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | cochlea development | 8.51e-05 | 61 | 29 | 3 | GO:0090102 | |
| GeneOntologyBiologicalProcess | mRNA processing | 9.95e-05 | 551 | 29 | 6 | GO:0006397 | |
| GeneOntologyBiologicalProcess | embryo development | 1.05e-04 | 1437 | 29 | 9 | GO:0009790 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 1.25e-04 | 12 | 29 | 2 | GO:0033148 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.75e-04 | 202 | 29 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity involved in neural tube closure | 1.98e-04 | 15 | 29 | 2 | GO:0090178 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection arborization | 1.98e-04 | 15 | 29 | 2 | GO:0150011 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 2.06e-04 | 906 | 29 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 2.22e-04 | 917 | 29 | 7 | GO:0016071 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity involved in neural tube closure | 2.26e-04 | 16 | 29 | 2 | GO:0090177 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 2.40e-04 | 929 | 29 | 7 | GO:0009792 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 2.45e-04 | 87 | 29 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity of embryonic epithelium | 2.88e-04 | 18 | 29 | 2 | GO:0042249 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 2.88e-04 | 18 | 29 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 3.22e-04 | 19 | 29 | 2 | GO:0090175 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 3.58e-04 | 99 | 29 | 3 | GO:0000245 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 3.60e-04 | 244 | 29 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 3.88e-04 | 249 | 29 | 4 | GO:0035264 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.02e-04 | 713 | 29 | 6 | GO:0048598 | |
| GeneOntologyBiologicalProcess | sensory organ development | 4.55e-04 | 730 | 29 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | neural tube closure | 5.27e-04 | 113 | 29 | 3 | GO:0001843 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 5.41e-04 | 114 | 29 | 3 | GO:0050772 | |
| GeneOntologyBiologicalProcess | tube closure | 5.41e-04 | 114 | 29 | 3 | GO:0060606 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 5.70e-04 | 494 | 29 | 5 | GO:0031346 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 6.28e-04 | 120 | 29 | 3 | GO:0014020 | |
| GeneOntologyBiologicalProcess | cochlea morphogenesis | 7.57e-04 | 29 | 29 | 2 | GO:0090103 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 7.75e-04 | 129 | 29 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 7.75e-04 | 129 | 29 | 3 | GO:0042472 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 7.92e-04 | 301 | 29 | 4 | GO:0048588 | |
| GeneOntologyBiologicalProcess | neural tube formation | 8.66e-04 | 134 | 29 | 3 | GO:0001841 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 9.04e-04 | 136 | 29 | 3 | GO:0030518 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.01e-03 | 561 | 29 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 1.17e-03 | 36 | 29 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.28e-03 | 343 | 29 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.29e-03 | 154 | 29 | 3 | GO:0042471 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 1.30e-03 | 38 | 29 | 2 | GO:0140058 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.32e-03 | 155 | 29 | 3 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.39e-03 | 158 | 29 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.40e-03 | 351 | 29 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 1.42e-03 | 159 | 29 | 3 | GO:0001838 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.44e-03 | 354 | 29 | 4 | GO:0050769 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.45e-03 | 911 | 29 | 6 | GO:0048589 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.55e-03 | 1269 | 29 | 7 | GO:0009887 | |
| GeneOntologyBiologicalProcess | cell growth | 1.63e-03 | 625 | 29 | 5 | GO:0016049 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.63e-03 | 625 | 29 | 5 | GO:0051960 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 1.74e-03 | 44 | 29 | 2 | GO:0001736 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 1.80e-03 | 173 | 29 | 3 | GO:0072175 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 1.82e-03 | 45 | 29 | 2 | GO:0007164 | |
| GeneOntologyBiologicalProcess | tube formation | 2.25e-03 | 187 | 29 | 3 | GO:0035148 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 2.36e-03 | 190 | 29 | 3 | GO:0016331 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 2.43e-03 | 192 | 29 | 3 | GO:0050770 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 2.60e-03 | 416 | 29 | 4 | GO:0030522 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.64e-03 | 418 | 29 | 4 | GO:0051962 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 2.71e-03 | 55 | 29 | 2 | GO:0060071 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.71e-03 | 421 | 29 | 4 | GO:0060562 | |
| GeneOntologyBiologicalProcess | neural tube development | 2.80e-03 | 202 | 29 | 3 | GO:0021915 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 2.90e-03 | 57 | 29 | 2 | GO:0030520 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 3.00e-03 | 207 | 29 | 3 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 3.11e-03 | 59 | 29 | 2 | GO:0000381 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 3.25e-03 | 213 | 29 | 3 | GO:0030307 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 3.26e-03 | 443 | 29 | 4 | GO:1903311 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 3.42e-03 | 741 | 29 | 5 | GO:0006338 | |
| GeneOntologyBiologicalProcess | face development | 3.53e-03 | 63 | 29 | 2 | GO:0060324 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 3.58e-03 | 1090 | 29 | 6 | GO:0022603 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 3.66e-03 | 1095 | 29 | 6 | GO:0060284 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 2.15e-06 | 18 | 30 | 3 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 2.15e-06 | 18 | 30 | 3 | GO:0071010 | |
| GeneOntologyCellularComponent | U1 snRNP | 1.41e-05 | 33 | 30 | 3 | GO:0005685 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.30e-04 | 12 | 30 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.42e-04 | 215 | 30 | 4 | GO:0005681 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 3.48e-04 | 96 | 30 | 3 | GO:0097525 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 3.59e-04 | 97 | 30 | 3 | GO:0005684 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 4.79e-04 | 107 | 30 | 3 | GO:0030532 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 6.53e-04 | 119 | 30 | 3 | GO:0120114 | |
| GeneOntologyCellularComponent | chromatin | 8.87e-04 | 1480 | 30 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 9.02e-04 | 31 | 30 | 2 | GO:0030131 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 1.36e-03 | 38 | 30 | 2 | GO:0030125 | |
| GeneOntologyCellularComponent | nuclear body | 1.56e-03 | 903 | 30 | 6 | GO:0016604 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 2.16e-03 | 48 | 30 | 2 | GO:0030119 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.82e-03 | 1377 | 30 | 7 | GO:0140513 | |
| GeneOntologyCellularComponent | clathrin coat | 2.92e-03 | 56 | 30 | 2 | GO:0030118 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 3.46e-03 | 61 | 30 | 2 | GO:0030660 | |
| GeneOntologyCellularComponent | vesicle coat | 4.15e-03 | 67 | 30 | 2 | GO:0030120 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 4.66e-03 | 237 | 30 | 3 | GO:0030136 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 5.18e-03 | 75 | 30 | 2 | GO:0035097 | |
| HumanPheno | Supernumerary tooth | 2.35e-08 | 85 | 7 | 5 | HP:0011069 | |
| HumanPheno | Natal tooth | 9.07e-08 | 38 | 7 | 4 | HP:0000695 | |
| HumanPheno | Advanced eruption of teeth | 2.00e-07 | 46 | 7 | 4 | HP:0006288 | |
| HumanPheno | Abnormality of the dentition | 1.36e-05 | 1030 | 7 | 7 | HP:0000164 | |
| HumanPheno | High, narrow palate | 2.76e-05 | 156 | 7 | 4 | HP:0002705 | |
| HumanPheno | Hypoplastic heart | 3.83e-05 | 54 | 7 | 3 | HP:0001961 | |
| HumanPheno | Abnormal midface morphology | 4.23e-05 | 704 | 7 | 6 | HP:0000309 | |
| HumanPheno | Pilomatrixoma | 5.80e-05 | 9 | 7 | 2 | HP:0030434 | |
| HumanPheno | Abnormal number of teeth | 6.88e-05 | 421 | 7 | 5 | HP:0006483 | |
| HumanPheno | Narrow palate | 7.65e-05 | 202 | 7 | 4 | HP:0000189 | |
| HumanPheno | Broad hallux | 1.07e-04 | 76 | 7 | 3 | HP:0010055 | |
| HumanPheno | Vesicoureteral reflux | 1.09e-04 | 221 | 7 | 4 | HP:0000076 | |
| HumanPheno | Abnormality of dental eruption | 1.50e-04 | 240 | 7 | 4 | HP:0006292 | |
| HumanPheno | Broad toe | 1.60e-04 | 87 | 7 | 3 | HP:0001837 | |
| HumanPheno | Abnormal ureter physiology | 1.63e-04 | 245 | 7 | 4 | HP:0025634 | |
| HumanPheno | Abnormal 5th finger morphology | 1.73e-04 | 509 | 7 | 5 | HP:0004207 | |
| HumanPheno | Broad thumb | 1.77e-04 | 90 | 7 | 3 | HP:0011304 | |
| HumanPheno | Convex nasal ridge | 2.08e-04 | 95 | 7 | 3 | HP:0000444 | |
| HumanPheno | Abnormal nasal dorsum morphology | 2.12e-04 | 262 | 7 | 4 | HP:0011119 | |
| HumanPheno | Premature thelarche | 2.18e-04 | 17 | 7 | 2 | HP:0010314 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 2.26e-04 | 538 | 7 | 5 | HP:0005927 | |
| HumanPheno | Skin appendage neoplasm | 2.45e-04 | 18 | 7 | 2 | HP:0012842 | |
| HumanPheno | Abnormal eyelash morphology | 2.90e-04 | 284 | 7 | 4 | HP:0000499 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 3.04e-04 | 572 | 7 | 5 | HP:0006496 | |
| HumanPheno | Short phalanx of finger | 3.87e-04 | 306 | 7 | 4 | HP:0009803 | |
| HumanPheno | Agenesis of permanent teeth | 4.04e-04 | 23 | 7 | 2 | HP:0006349 | |
| HumanPheno | Inguinal hernia | 4.17e-04 | 312 | 7 | 4 | HP:0000023 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 4.54e-04 | 319 | 7 | 4 | HP:0009767 | |
| HumanPheno | Long eyelashes | 5.16e-04 | 129 | 7 | 3 | HP:0000527 | |
| HumanPheno | Perimembranous ventricular septal defect | 5.18e-04 | 26 | 7 | 2 | HP:0011682 | |
| HumanPheno | Cleft palate | 5.33e-04 | 643 | 7 | 5 | HP:0000175 | |
| HumanPheno | Abnormal hard palate morphology | 5.49e-04 | 647 | 7 | 5 | HP:0100737 | |
| HumanPheno | Patent foramen ovale | 5.89e-04 | 135 | 7 | 3 | HP:0001655 | |
| HumanPheno | Abnormal earlobe morphology | 6.15e-04 | 137 | 7 | 3 | HP:0000363 | |
| HumanPheno | Short columella | 6.46e-04 | 29 | 7 | 2 | HP:0002000 | |
| HumanPheno | Abnormal testis morphology | 6.66e-04 | 1129 | 7 | 6 | HP:0000035 | |
| HumanPheno | Abnormal eyebrow morphology | 6.67e-04 | 674 | 7 | 5 | HP:0000534 | |
| HumanPheno | Non-obstructive azoospermia | 6.76e-04 | 1132 | 7 | 6 | HP:0011961 | |
| HumanPheno | Abnormality of calvarial morphology | 6.83e-04 | 1134 | 7 | 6 | HP:0002648 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 6.91e-04 | 30 | 7 | 2 | HP:0005743 | |
| HumanPheno | Craniofacial cleft | 7.67e-04 | 694 | 7 | 5 | HP:5201015 | |
| HumanPheno | Orofacial cleft | 7.67e-04 | 694 | 7 | 5 | HP:0000202 | |
| HumanPheno | Azoospermia | 7.67e-04 | 1157 | 7 | 6 | HP:0000027 | |
| HumanPheno | Broad phalanx | 7.72e-04 | 148 | 7 | 3 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 7.72e-04 | 148 | 7 | 3 | HP:0009768 | |
| HumanPheno | Coarctation of aorta | 8.03e-04 | 150 | 7 | 3 | HP:0001680 | |
| HumanPheno | Sparse eyebrow | 8.19e-04 | 151 | 7 | 3 | HP:0045075 | |
| HumanPheno | Proportionate short stature | 8.51e-04 | 153 | 7 | 3 | HP:0003508 | |
| HumanPheno | Broad finger | 8.67e-04 | 154 | 7 | 3 | HP:0001500 | |
| HumanPheno | Dental malocclusion | 9.01e-04 | 156 | 7 | 3 | HP:0000689 | |
| HumanPheno | Abnormal spermatogenesis | 9.02e-04 | 1190 | 7 | 6 | HP:0008669 | |
| HumanPheno | Abnormality of the ureter | 9.17e-04 | 383 | 7 | 4 | HP:0000069 | |
| HumanPheno | Broad long bones | 9.18e-04 | 157 | 7 | 3 | HP:0005622 | |
| HumanPheno | Abnormal number of permanent teeth | 9.43e-04 | 35 | 7 | 2 | HP:0011044 | |
| HumanPheno | Abnormal palate morphology | 9.56e-04 | 1202 | 7 | 6 | HP:0000174 | |
| HumanPheno | Hydrocele testis | 9.97e-04 | 36 | 7 | 2 | HP:0000034 | |
| HumanPheno | Nasolacrimal duct obstruction | 9.97e-04 | 36 | 7 | 2 | HP:0000579 | |
| HumanPheno | Frontal bossing | 1.03e-03 | 738 | 7 | 5 | HP:0002007 | |
| HumanPheno | Abnormal shape of the frontal region | 1.05e-03 | 741 | 7 | 5 | HP:0011218 | |
| HumanPheno | Abnormal frontal bone morphology | 1.05e-03 | 742 | 7 | 5 | HP:0430000 | |
| HumanPheno | Abnormal male internal genitalia morphology | 1.16e-03 | 1243 | 7 | 6 | HP:0000022 | |
| HumanPheno | Capillary hemangioma | 1.17e-03 | 39 | 7 | 2 | HP:0005306 | |
| HumanPheno | Aplasia involving bones of the extremities | 1.17e-03 | 759 | 7 | 5 | HP:0009825 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 1.19e-03 | 761 | 7 | 5 | HP:0045060 | |
| HumanPheno | Telecanthus | 1.22e-03 | 173 | 7 | 3 | HP:0000506 | |
| HumanPheno | Abnormal calvaria morphology | 1.22e-03 | 1254 | 7 | 6 | HP:0002683 | |
| HumanPheno | Tooth malposition | 1.28e-03 | 418 | 7 | 4 | HP:0000692 | |
| HumanPheno | Clinodactyly of the 5th finger | 1.30e-03 | 420 | 7 | 4 | HP:0004209 | |
| HumanPheno | Functional abnormality of male internal genitalia | 1.31e-03 | 1269 | 7 | 6 | HP:0000025 | |
| HumanPheno | Clinodactyly of hands | 1.32e-03 | 421 | 7 | 4 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 1.32e-03 | 421 | 7 | 4 | HP:0009179 | |
| HumanPheno | Juvenile aseptic necrosis | 1.42e-03 | 43 | 7 | 2 | HP:0100323 | |
| HumanPheno | Brachydactyly (hand) | 1.43e-03 | 430 | 7 | 4 | HP:0100667 | |
| HumanPheno | Cleft upper lip | 1.43e-03 | 183 | 7 | 3 | HP:0000204 | |
| HumanPheno | Abnormal heart morphology | 1.46e-03 | 184 | 7 | 3 | HP:3000001 | |
| HumanPheno | Smooth philtrum | 1.48e-03 | 185 | 7 | 3 | HP:0000319 | |
| HumanPheno | Precocious puberty | 1.50e-03 | 186 | 7 | 3 | HP:0000826 | |
| HumanPheno | Early onset of sexual maturation | 1.58e-03 | 189 | 7 | 3 | HP:0100000 | |
| HumanPheno | Abnormal male reproductive system physiology | 1.59e-03 | 1314 | 7 | 6 | HP:0012874 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 1.62e-03 | 813 | 7 | 5 | HP:0009815 | |
| HumanPheno | Flared metaphysis | 1.62e-03 | 191 | 7 | 3 | HP:0003015 | |
| HumanPheno | Prominent fingertip pads | 1.63e-03 | 46 | 7 | 2 | HP:0001212 | |
| HumanPheno | Secundum atrial septal defect | 1.63e-03 | 46 | 7 | 2 | HP:0001684 | |
| HumanPheno | Radial deviation of finger | 1.67e-03 | 448 | 7 | 4 | HP:0009466 | |
| HumanPheno | Abnormal thorax morphology | 1.69e-03 | 1328 | 7 | 6 | HP:0000765 | |
| HumanPheno | Abnormal male external genitalia morphology | 1.70e-03 | 1329 | 7 | 6 | HP:0000032 | |
| HumanPheno | Finger clinodactyly | 1.72e-03 | 452 | 7 | 4 | HP:0040019 | |
| HumanPheno | Chiari type I malformation | 1.77e-03 | 48 | 7 | 2 | HP:0007099 | |
| HumanPheno | Prominent digit pad | 1.77e-03 | 48 | 7 | 2 | HP:0011298 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 1.78e-03 | 456 | 7 | 4 | HP:0009485 | |
| HumanPheno | Hypoplastic left heart | 1.85e-03 | 49 | 7 | 2 | HP:0004383 | |
| HumanPheno | Tracheomalacia | 1.85e-03 | 49 | 7 | 2 | HP:0002779 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.92e-03 | 50 | 7 | 2 | HP:0011481 | |
| HumanPheno | Abnormality of thumb phalanx | 1.99e-03 | 205 | 7 | 3 | HP:0009602 | |
| HumanPheno | Congenital malformation of the left heart | 2.00e-03 | 51 | 7 | 2 | HP:0045017 | |
| HumanPheno | Highly arched eyebrow | 2.02e-03 | 206 | 7 | 3 | HP:0002553 | |
| HumanPheno | Abnormal external genitalia | 2.04e-03 | 1372 | 7 | 6 | HP:0000811 | |
| HumanPheno | Abnormal finger morphology | 2.15e-03 | 1385 | 7 | 6 | HP:0001167 | |
| HumanPheno | Abnormal hallux morphology | 2.20e-03 | 212 | 7 | 3 | HP:0001844 | |
| Domain | BAT2_N | 6.98e-06 | 3 | 29 | 2 | IPR009738 | |
| Domain | BAT2_N | 6.98e-06 | 3 | 29 | 2 | PF07001 | |
| Domain | Dsh_C | 6.98e-06 | 3 | 29 | 2 | PF12316 | |
| Domain | PRRC2 | 6.98e-06 | 3 | 29 | 2 | IPR033184 | |
| Domain | Dishevelled_C-dom | 6.98e-06 | 3 | 29 | 2 | IPR024580 | |
| Domain | Dishevelled | 1.39e-05 | 4 | 29 | 2 | PF02377 | |
| Domain | - | 1.39e-05 | 4 | 29 | 2 | 1.10.10.440 | |
| Domain | Dsh/Dvl-rel | 1.39e-05 | 4 | 29 | 2 | IPR015506 | |
| Domain | Dishevelled_protein_dom | 1.39e-05 | 4 | 29 | 2 | IPR003351 | |
| Domain | Dishevelled_fam | 1.39e-05 | 4 | 29 | 2 | IPR008339 | |
| Domain | FYrich_C | 2.32e-05 | 5 | 29 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.32e-05 | 5 | 29 | 2 | IPR003888 | |
| Domain | FYRC | 2.32e-05 | 5 | 29 | 2 | SM00542 | |
| Domain | FYRN | 2.32e-05 | 5 | 29 | 2 | SM00541 | |
| Domain | FYRN | 2.32e-05 | 5 | 29 | 2 | PF05964 | |
| Domain | FYRC | 2.32e-05 | 5 | 29 | 2 | PF05965 | |
| Domain | FYRC | 2.32e-05 | 5 | 29 | 2 | PS51543 | |
| Domain | FYRN | 2.32e-05 | 5 | 29 | 2 | PS51542 | |
| Domain | FF | 3.48e-05 | 6 | 29 | 2 | PF01846 | |
| Domain | FF | 3.48e-05 | 6 | 29 | 2 | SM00441 | |
| Domain | Nuc_rcpt_coact | 3.48e-05 | 6 | 29 | 2 | IPR009110 | |
| Domain | FF | 3.48e-05 | 6 | 29 | 2 | PS51676 | |
| Domain | FF_domain | 3.48e-05 | 6 | 29 | 2 | IPR002713 | |
| Domain | DIX | 4.87e-05 | 7 | 29 | 2 | IPR001158 | |
| Domain | DIX | 4.87e-05 | 7 | 29 | 2 | PS50841 | |
| Domain | DAX | 4.87e-05 | 7 | 29 | 2 | SM00021 | |
| Domain | DIX | 4.87e-05 | 7 | 29 | 2 | PF00778 | |
| Domain | Post-SET_dom | 2.76e-04 | 16 | 29 | 2 | IPR003616 | |
| Domain | PostSET | 2.76e-04 | 16 | 29 | 2 | SM00508 | |
| Domain | POST_SET | 2.76e-04 | 16 | 29 | 2 | PS50868 | |
| Domain | DEP | 5.27e-04 | 22 | 29 | 2 | PF00610 | |
| Domain | EPHD | 5.27e-04 | 22 | 29 | 2 | PS51805 | |
| Domain | DEP | 5.27e-04 | 22 | 29 | 2 | SM00049 | |
| Domain | DEP | 5.27e-04 | 22 | 29 | 2 | PS50186 | |
| Domain | DEP_dom | 5.77e-04 | 23 | 29 | 2 | IPR000591 | |
| Domain | SET | 1.84e-03 | 41 | 29 | 2 | PF00856 | |
| Domain | SET | 2.31e-03 | 46 | 29 | 2 | SM00317 | |
| Domain | WW | 2.41e-03 | 47 | 29 | 2 | PF00397 | |
| Domain | WW | 2.51e-03 | 48 | 29 | 2 | SM00456 | |
| Domain | SET_dom | 2.72e-03 | 50 | 29 | 2 | IPR001214 | |
| Domain | SET | 2.72e-03 | 50 | 29 | 2 | PS50280 | |
| Domain | WW_DOMAIN_2 | 2.83e-03 | 51 | 29 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 2.83e-03 | 51 | 29 | 2 | PS01159 | |
| Domain | WW_dom | 2.94e-03 | 52 | 29 | 2 | IPR001202 | |
| Domain | HMG_box | 3.05e-03 | 53 | 29 | 2 | PF00505 | |
| Domain | HMG | 3.17e-03 | 54 | 29 | 2 | SM00398 | |
| Domain | RRM | 4.52e-03 | 217 | 29 | 3 | SM00360 | |
| Domain | HMG_box_dom | 4.56e-03 | 65 | 29 | 2 | IPR009071 | |
| Domain | RRM_dom | 5.13e-03 | 227 | 29 | 3 | IPR000504 | |
| Domain | RRM | 5.32e-03 | 230 | 29 | 3 | PS50102 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.67e-06 | 122 | 24 | 5 | M29689 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 3.48e-06 | 18 | 24 | 3 | M31 | |
| Pathway | WP_MRNA_PROCESSING | 7.07e-06 | 451 | 24 | 7 | MM15946 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.71e-05 | 30 | 24 | 3 | M207 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS | 2.77e-05 | 5 | 24 | 2 | M27447 | |
| Pathway | KEGG_SPLICEOSOME | 5.81e-05 | 127 | 24 | 4 | M2044 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.69e-05 | 47 | 24 | 3 | M7946 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 7.73e-05 | 8 | 24 | 2 | M27100 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 9.93e-05 | 9 | 24 | 2 | MM14792 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.36e-04 | 158 | 24 | 4 | MM14791 | |
| Pathway | REACTOME_KILLING_MECHANISMS | 1.81e-04 | 12 | 24 | 2 | M29844 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 3.27e-04 | 80 | 24 | 3 | M223 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.29e-04 | 16 | 24 | 2 | M27121 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M47823 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.41e-04 | 201 | 24 | 4 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 4.17e-04 | 212 | 24 | 4 | M14033 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 5.18e-04 | 20 | 24 | 2 | M90 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 5.58e-04 | 96 | 24 | 3 | M27792 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 5.96e-04 | 233 | 24 | 4 | M27099 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.28e-04 | 22 | 24 | 2 | MM1370 | |
| Pathway | KEGG_MELANOGENESIS | 6.48e-04 | 101 | 24 | 3 | M7761 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 6.48e-04 | 101 | 24 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 6.48e-04 | 101 | 24 | 3 | M39387 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 6.56e-04 | 239 | 24 | 4 | MM14756 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 8.30e-04 | 110 | 24 | 3 | MM15977 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 8.81e-04 | 26 | 24 | 2 | MM14793 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.14e-03 | 277 | 24 | 4 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.23e-03 | 283 | 24 | 4 | M13087 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.25e-03 | 31 | 24 | 2 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.25e-03 | 31 | 24 | 2 | MM15154 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.34e-03 | 32 | 24 | 2 | M23 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.51e-03 | 34 | 24 | 2 | M39771 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.69e-03 | 36 | 24 | 2 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.78e-03 | 37 | 24 | 2 | M47411 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.07e-03 | 151 | 24 | 3 | M19428 | |
| Pathway | PID_FOXM1_PATHWAY | 2.08e-03 | 40 | 24 | 2 | M176 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.16e-03 | 330 | 24 | 4 | M7847 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.19e-03 | 154 | 24 | 3 | M39739 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.29e-03 | 42 | 24 | 2 | M17541 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.29e-03 | 42 | 24 | 2 | M48018 | |
| Pathway | PID_HNF3A_PATHWAY | 2.52e-03 | 44 | 24 | 2 | M285 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.52e-03 | 44 | 24 | 2 | MM15878 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.52e-03 | 44 | 24 | 2 | MM15527 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.63e-03 | 45 | 24 | 2 | M39571 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.63e-03 | 45 | 24 | 2 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 2.75e-03 | 46 | 24 | 2 | M47409 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.75e-03 | 46 | 24 | 2 | MM15971 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 3.37e-03 | 51 | 24 | 2 | M39721 | |
| Pathway | PID_TAP63_PATHWAY | 3.77e-03 | 54 | 24 | 2 | M256 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 3.90e-03 | 55 | 24 | 2 | M17807 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 3.90e-03 | 55 | 24 | 2 | MM15153 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 4.19e-03 | 57 | 24 | 2 | M27399 | |
| Pathway | PID_NOTCH_PATHWAY | 4.48e-03 | 59 | 24 | 2 | M17 | |
| Pathway | WP_WNT_SIGNALING | 4.78e-03 | 61 | 24 | 2 | MM15893 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 5.25e-03 | 64 | 24 | 2 | M200 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 5.41e-03 | 65 | 24 | 2 | M39374 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.41e-03 | 65 | 24 | 2 | M39682 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 5.58e-03 | 66 | 24 | 2 | M101 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 6.25e-03 | 70 | 24 | 2 | M27231 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA3 KMT2C KMT2D PRPF40B SNRPC RBM33 PRPF40A PRRC2C EP300 MBNL1 | 3.31e-12 | 457 | 30 | 10 | 32344865 |
| Pubmed | 3.64e-11 | 399 | 30 | 9 | 35987950 | ||
| Pubmed | NCOA3 KMT2C CHD6 RBM25 KMT2D SMAP2 RBM33 SOBP PRPF40A PRRC2A PRRC2C EP300 MBNL1 | 5.62e-11 | 1429 | 30 | 13 | 35140242 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 28398509 | ||
| Pubmed | 3.44e-09 | 152 | 30 | 6 | 38360978 | ||
| Pubmed | 1.58e-08 | 549 | 30 | 8 | 38280479 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.13e-08 | 220 | 30 | 6 | 35785414 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 4.42e-08 | 113 | 30 | 5 | 23403292 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 7.22e-08 | 954 | 30 | 9 | 36373674 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.32e-07 | 724 | 30 | 8 | 36232890 | |
| Pubmed | 1.72e-07 | 57 | 30 | 4 | 18022353 | ||
| Pubmed | 2.47e-07 | 1103 | 30 | 9 | 34189442 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.02e-07 | 807 | 30 | 8 | 22681889 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28483418 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 36869380 | ||
| Pubmed | Genetic analysis of disheveled 2 and disheveled 3 in human neural tube defects. | 7.19e-07 | 2 | 30 | 2 | 22892949 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28967912 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 7.19e-07 | 2 | 30 | 2 | 34156443 | |
| Pubmed | Planar polarization of node cells determines the rotational axis of node cilia. | 7.19e-07 | 2 | 30 | 2 | 20098415 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25346535 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26464018 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31924266 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27280393 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23022960 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 36601880 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 21092292 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 28366812 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 25605964 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 2.16e-06 | 3 | 30 | 2 | 11823864 | |
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 2.16e-06 | 3 | 30 | 2 | 22183980 | |
| Pubmed | AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. | 2.16e-06 | 3 | 30 | 2 | 10866661 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15145939 | ||
| Pubmed | Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3. | 2.16e-06 | 3 | 30 | 2 | 18093802 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 8973355 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18692936 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 32900645 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27744318 | ||
| Pubmed | Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. | 2.16e-06 | 3 | 30 | 2 | 27086035 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 37410700 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19137009 | ||
| Pubmed | A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. | 2.16e-06 | 3 | 30 | 2 | 14618241 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23932714 | ||
| Pubmed | The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. | 2.16e-06 | 3 | 30 | 2 | 12569362 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 28732206 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 21683083 | ||
| Pubmed | Dishevelled proteins are associated with olfactory sensory neuron presynaptic terminals. | 2.16e-06 | 3 | 30 | 2 | 23437169 | |
| Pubmed | 2.63e-06 | 469 | 30 | 6 | 27634302 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.65e-06 | 258 | 30 | 5 | 37794589 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.43e-06 | 774 | 30 | 7 | 15302935 | |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 4.31e-06 | 4 | 30 | 2 | 19221051 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 34645806 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 24643799 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 4.31e-06 | 4 | 30 | 2 | 10655477 | |
| Pubmed | DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling. | 4.31e-06 | 4 | 30 | 2 | 25557784 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 16227615 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 8817329 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 33589584 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 4.31e-06 | 4 | 30 | 2 | 9192851 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 32668201 | ||
| Pubmed | Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways. | 4.31e-06 | 4 | 30 | 2 | 17593335 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 24081332 | ||
| Pubmed | Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. | 4.31e-06 | 4 | 30 | 2 | 19625296 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 11701890 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 25043421 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 4.31e-06 | 4 | 30 | 2 | 23129768 | |
| Pubmed | Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. | 4.31e-06 | 4 | 30 | 2 | 19465938 | |
| Pubmed | Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling. | 4.31e-06 | 4 | 30 | 2 | 23371553 | |
| Pubmed | Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation. | 4.31e-06 | 4 | 30 | 2 | 18772438 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 4.74e-06 | 130 | 30 | 4 | 35545047 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 9724750 | ||
| Pubmed | Structure of a biologically active estrogen receptor-coactivator complex on DNA. | 7.18e-06 | 5 | 30 | 2 | 25728767 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 20137080 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 15456783 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 25424568 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 24469800 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 22826439 | ||
| Pubmed | MLL3/MLL4-Associated PAGR1 Regulates Adipogenesis by Controlling Induction of C/EBPβ and C/EBPδ. | 7.18e-06 | 5 | 30 | 2 | 32601106 | |
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 7.18e-06 | 5 | 30 | 2 | 9812974 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 12714702 | ||
| Pubmed | Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF. | 7.18e-06 | 5 | 30 | 2 | 31127101 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 10336495 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 30418174 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 26744420 | ||
| Pubmed | 9.41e-06 | 335 | 30 | 5 | 15741177 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.01e-05 | 1294 | 30 | 8 | 30804502 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 24427302 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 1.08e-05 | 6 | 30 | 2 | 11076796 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 32579954 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 34139860 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 21880741 | ||
| Pubmed | Structural and Functional Impacts of ER Coactivator Sequential Recruitment. | 1.08e-05 | 6 | 30 | 2 | 28844863 | |
| Pubmed | Roles of coactivators in hypoxic induction of the erythropoietin gene. | 1.08e-05 | 6 | 30 | 2 | 20368990 | |
| Pubmed | SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. | 1.08e-05 | 6 | 30 | 2 | 20439735 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 16923966 | ||
| Pubmed | Activation of rapid oestrogen signalling in aggressive human breast cancers. | 1.08e-05 | 6 | 30 | 2 | 23065768 | |
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 1.08e-05 | 6 | 30 | 2 | 17021013 | |
| Pubmed | 1.16e-05 | 608 | 30 | 6 | 16713569 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.16e-05 | 1318 | 30 | 8 | 30463901 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.17e-05 | 934 | 30 | 7 | 33916271 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.18e-05 | 351 | 30 | 5 | 38297188 | |
| Interaction | ALG13 interactions | NCOA3 RBM25 KMT2D SMAP2 RBM33 PRPF40A PRRC2A PRRC2C SF1 EP300 | 7.64e-14 | 183 | 30 | 10 | int:ALG13 |
| Interaction | NUP35 interactions | NCOA3 KMT2C KMT2D PRPF40B SNRPC RBM33 PRPF40A PRRC2C EP300 MBNL1 | 3.15e-10 | 424 | 30 | 10 | int:NUP35 |
| Interaction | WWTR1 interactions | 6.89e-09 | 422 | 30 | 9 | int:WWTR1 | |
| Interaction | SP7 interactions | 1.07e-08 | 304 | 30 | 8 | int:SP7 | |
| Interaction | EYA4 interactions | 5.46e-08 | 243 | 30 | 7 | int:EYA4 | |
| Interaction | DAZL interactions | 6.44e-08 | 145 | 30 | 6 | int:DAZL | |
| Interaction | ELF5 interactions | 6.99e-08 | 147 | 30 | 6 | int:ELF5 | |
| Interaction | KLF4 interactions | 1.16e-07 | 160 | 30 | 6 | int:KLF4 | |
| Interaction | KLF15 interactions | 1.82e-07 | 290 | 30 | 7 | int:KLF15 | |
| Interaction | SNRPA interactions | 3.72e-07 | 482 | 30 | 8 | int:SNRPA | |
| Interaction | PAX7 interactions | 1.02e-06 | 124 | 30 | 5 | int:PAX7 | |
| Interaction | TLE3 interactions | 1.05e-06 | 376 | 30 | 7 | int:TLE3 | |
| Interaction | PAX9 interactions | 1.29e-06 | 130 | 30 | 5 | int:PAX9 | |
| Interaction | CRX interactions | 1.74e-06 | 254 | 30 | 6 | int:CRX | |
| Interaction | FAM168A interactions | 2.00e-06 | 142 | 30 | 5 | int:FAM168A | |
| Interaction | NCOA1 interactions | 2.29e-06 | 146 | 30 | 5 | int:NCOA1 | |
| Interaction | GCM1 interactions | 3.04e-06 | 68 | 30 | 4 | int:GCM1 | |
| Interaction | SOX6 interactions | 3.28e-06 | 157 | 30 | 5 | int:SOX6 | |
| Interaction | RPA4 interactions | 3.55e-06 | 452 | 30 | 7 | int:RPA4 | |
| Interaction | CELF1 interactions | 3.60e-06 | 288 | 30 | 6 | int:CELF1 | |
| Interaction | PRPF3 interactions | 3.82e-06 | 291 | 30 | 6 | int:PRPF3 | |
| Interaction | SOX5 interactions | 3.82e-06 | 162 | 30 | 5 | int:SOX5 | |
| Interaction | FUBP3 interactions | 4.29e-06 | 297 | 30 | 6 | int:FUBP3 | |
| Interaction | TLX1 interactions | 5.57e-06 | 175 | 30 | 5 | int:TLX1 | |
| Interaction | HNF1A interactions | 5.83e-06 | 80 | 30 | 4 | int:HNF1A | |
| Interaction | ZBTB8A interactions | 6.13e-06 | 81 | 30 | 4 | int:ZBTB8A | |
| Interaction | SOX7 interactions | 6.44e-06 | 82 | 30 | 4 | int:SOX7 | |
| Interaction | DDX6 interactions | 7.16e-06 | 503 | 30 | 7 | int:DDX6 | |
| Interaction | IRF4 interactions | 7.43e-06 | 85 | 30 | 4 | int:IRF4 | |
| Interaction | GSC interactions | 8.15e-06 | 87 | 30 | 4 | int:GSC | |
| Interaction | CPSF7 interactions | 9.00e-06 | 338 | 30 | 6 | int:CPSF7 | |
| Interaction | KLF5 interactions | 9.43e-06 | 195 | 30 | 5 | int:KLF5 | |
| Interaction | SNW1 interactions | 9.73e-06 | 747 | 30 | 8 | int:SNW1 | |
| Interaction | SMC5 interactions | 9.78e-06 | 1000 | 30 | 9 | int:SMC5 | |
| Interaction | FOXI1 interactions | 1.02e-05 | 92 | 30 | 4 | int:FOXI1 | |
| Interaction | GATA2 interactions | 1.04e-05 | 199 | 30 | 5 | int:GATA2 | |
| Interaction | BEND7 interactions | 1.11e-05 | 94 | 30 | 4 | int:BEND7 | |
| Interaction | FEV interactions | 1.15e-05 | 203 | 30 | 5 | int:FEV | |
| Interaction | NEIL3 interactions | 1.26e-05 | 97 | 30 | 4 | int:NEIL3 | |
| Interaction | SOX9 interactions | 1.26e-05 | 97 | 30 | 4 | int:SOX9 | |
| Interaction | RBM39 interactions | 1.36e-05 | 1042 | 30 | 9 | int:RBM39 | |
| Interaction | PAX6 interactions | 1.41e-05 | 366 | 30 | 6 | int:PAX6 | |
| Interaction | ERG interactions | 1.80e-05 | 223 | 30 | 5 | int:ERG | |
| Interaction | FOXK2 interactions | 1.88e-05 | 225 | 30 | 5 | int:FOXK2 | |
| Interaction | KLF3 interactions | 2.01e-05 | 228 | 30 | 5 | int:KLF3 | |
| Interaction | PAX8 interactions | 2.14e-05 | 111 | 30 | 4 | int:PAX8 | |
| Interaction | KLF1 interactions | 2.24e-05 | 37 | 30 | 3 | int:KLF1 | |
| Interaction | PSMF1 interactions | 2.29e-05 | 113 | 30 | 4 | int:PSMF1 | |
| Interaction | TBR1 interactions | 2.29e-05 | 113 | 30 | 4 | int:TBR1 | |
| Interaction | AP1B1 interactions | 2.42e-05 | 237 | 30 | 5 | int:AP1B1 | |
| Interaction | TBXT interactions | 2.54e-05 | 116 | 30 | 4 | int:TBXT | |
| Interaction | LUC7L interactions | 2.67e-05 | 242 | 30 | 5 | int:LUC7L | |
| Interaction | BAG2 interactions | 2.83e-05 | 622 | 30 | 7 | int:BAG2 | |
| Interaction | CHEK2 interactions | 3.12e-05 | 250 | 30 | 5 | int:CHEK2 | |
| Interaction | RNPS1 interactions | 3.28e-05 | 425 | 30 | 6 | int:RNPS1 | |
| Interaction | NPAS2 interactions | 3.29e-05 | 42 | 30 | 3 | int:NPAS2 | |
| Interaction | CPSF1 interactions | 3.43e-05 | 255 | 30 | 5 | int:CPSF1 | |
| Interaction | SNRPB2 interactions | 3.43e-05 | 255 | 30 | 5 | int:SNRPB2 | |
| Interaction | RARB interactions | 4.33e-05 | 46 | 30 | 3 | int:RARB | |
| Interaction | SORCS3 interactions | 4.48e-05 | 7 | 30 | 2 | int:SORCS3 | |
| Interaction | CWC15 interactions | 4.48e-05 | 134 | 30 | 4 | int:CWC15 | |
| Interaction | BCAS2 interactions | 4.51e-05 | 270 | 30 | 5 | int:BCAS2 | |
| Interaction | SRRM2 interactions | 5.23e-05 | 462 | 30 | 6 | int:SRRM2 | |
| Interaction | SOX15 interactions | 5.46e-05 | 141 | 30 | 4 | int:SOX15 | |
| Interaction | CEBPA interactions | 5.57e-05 | 1245 | 30 | 9 | int:CEBPA | |
| Interaction | MAB21L2 interactions | 5.77e-05 | 143 | 30 | 4 | int:MAB21L2 | |
| Interaction | NCOA6 interactions | 6.09e-05 | 145 | 30 | 4 | int:NCOA6 | |
| Interaction | TLX3 interactions | 6.43e-05 | 291 | 30 | 5 | int:TLX3 | |
| Interaction | MAP2K1 interactions | 6.64e-05 | 293 | 30 | 5 | int:MAP2K1 | |
| Interaction | MFAP1 interactions | 6.86e-05 | 295 | 30 | 5 | int:MFAP1 | |
| Interaction | AP1G1 interactions | 6.95e-05 | 150 | 30 | 4 | int:AP1G1 | |
| Interaction | IFI6 interactions | 7.01e-05 | 54 | 30 | 3 | int:IFI6 | |
| Interaction | SNRPA1 interactions | 7.42e-05 | 300 | 30 | 5 | int:SNRPA1 | |
| Interaction | SAP18 interactions | 8.03e-05 | 305 | 30 | 5 | int:SAP18 | |
| Interaction | NCBP3 interactions | 8.09e-05 | 156 | 30 | 4 | int:NCBP3 | |
| Interaction | RARG interactions | 8.69e-05 | 58 | 30 | 3 | int:RARG | |
| Interaction | PRPF38A interactions | 9.15e-05 | 161 | 30 | 4 | int:PRPF38A | |
| Interaction | SSBP4 interactions | 9.15e-05 | 59 | 30 | 3 | int:SSBP4 | |
| Interaction | EEA1 interactions | 9.37e-05 | 162 | 30 | 4 | int:EEA1 | |
| Interaction | FSAF1 interactions | 9.62e-05 | 60 | 30 | 3 | int:FSAF1 | |
| Interaction | SMG7 interactions | 9.91e-05 | 319 | 30 | 5 | int:SMG7 | |
| Interaction | ETS2 interactions | 1.01e-04 | 61 | 30 | 3 | int:ETS2 | |
| Interaction | RBM25 interactions | 1.05e-04 | 323 | 30 | 5 | int:RBM25 | |
| Interaction | FOXA1 interactions | 1.06e-04 | 525 | 30 | 6 | int:FOXA1 | |
| Interaction | RBM11 interactions | 1.10e-04 | 169 | 30 | 4 | int:RBM11 | |
| Interaction | KLF8 interactions | 1.15e-04 | 329 | 30 | 5 | int:KLF8 | |
| Interaction | PRP4K interactions | 1.15e-04 | 329 | 30 | 5 | int:PRP4K | |
| Interaction | EGR2 interactions | 1.15e-04 | 171 | 30 | 4 | int:EGR2 | |
| Interaction | IFI27L1 interactions | 1.22e-04 | 65 | 30 | 3 | int:IFI27L1 | |
| Interaction | RBPMS interactions | 1.34e-04 | 340 | 30 | 5 | int:RBPMS | |
| Interaction | ETV4 interactions | 1.46e-04 | 69 | 30 | 3 | int:ETV4 | |
| Interaction | GATA3 interactions | 1.63e-04 | 187 | 30 | 4 | int:GATA3 | |
| Interaction | ATN1 interactions | 1.63e-04 | 187 | 30 | 4 | int:ATN1 | |
| Interaction | ASCL2 interactions | 1.65e-04 | 13 | 30 | 2 | int:ASCL2 | |
| Interaction | NFIA interactions | 1.66e-04 | 188 | 30 | 4 | int:NFIA | |
| Interaction | SMAP2 interactions | 1.70e-04 | 189 | 30 | 4 | int:SMAP2 | |
| Interaction | PAXIP1 interactions | 1.72e-04 | 359 | 30 | 5 | int:PAXIP1 | |
| Interaction | HNF1B interactions | 1.73e-04 | 190 | 30 | 4 | int:HNF1B | |
| Interaction | CEBPB interactions | 1.74e-04 | 1443 | 30 | 9 | int:CEBPB | |
| Interaction | MYOD1 interactions | 1.88e-04 | 194 | 30 | 4 | int:MYOD1 | |
| Cytoband | 20q12 | 1.13e-04 | 24 | 30 | 2 | 20q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 1.55e-04 | 159 | 30 | 3 | chr7q36 | |
| Cytoband | 7q36.1 | 1.08e-03 | 74 | 30 | 2 | 7q36.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.62e-03 | 423 | 30 | 3 | chr12q13 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 6.27e-06 | 4 | 19 | 2 | 505 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.41e-04 | 17 | 19 | 2 | 486 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.09e-04 | 25 | 19 | 2 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.75e-04 | 34 | 19 | 2 | 487 | |
| GeneFamily | RNA binding motif containing | 1.36e-03 | 213 | 19 | 3 | 725 | |
| GeneFamily | PHD finger proteins | 3.97e-03 | 90 | 19 | 2 | 88 | |
| GeneFamily | PDZ domain containing | 1.09e-02 | 152 | 19 | 2 | 1220 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 3.64e-06 | 1492 | 30 | 10 | M40023 | |
| Coexpression | GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 3.24e-05 | 160 | 30 | 4 | M7116 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 7.57e-05 | 199 | 30 | 4 | M9443 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 7.72e-05 | 200 | 30 | 4 | M5991 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.60e-05 | 843 | 30 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.91e-05 | 37 | 30 | 3 | gudmap_kidney_P0_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 5.68e-05 | 53 | 30 | 3 | gudmap_kidney_P1_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.63e-04 | 197 | 30 | 4 | gudmap_developingGonad_e11.5_testes_k2_1000 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.89e-09 | 200 | 30 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.89e-09 | 200 | 30 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-07 | 197 | 30 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.81e-06 | 147 | 30 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.12e-06 | 179 | 30 | 4 | fad1fbee002fcd424c03460d695559060ce41a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.12e-06 | 179 | 30 | 4 | 6d4e4b64e633b2ae8514ffa1e45829d6508dac54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.12e-06 | 179 | 30 | 4 | 61a7cc01fae4115325fce0efaa5bacf8f9af5ba2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.08e-06 | 192 | 30 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.24e-06 | 193 | 30 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.94e-06 | 197 | 30 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.94e-06 | 197 | 30 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.12e-06 | 198 | 30 | 4 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.12e-06 | 198 | 30 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.12e-06 | 198 | 30 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.12e-06 | 198 | 30 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 9.30e-06 | 199 | 30 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.55e-04 | 156 | 30 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.73e-04 | 162 | 30 | 3 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 168 | 30 | 3 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | C_00|World / shred on cell type and cluster | 2.32e-04 | 179 | 30 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 30 | 3 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 30 | 3 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.56e-04 | 185 | 30 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-04 | 186 | 30 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 187 | 30 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.68e-04 | 188 | 30 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-04 | 189 | 30 | 3 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-04 | 191 | 30 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | CV-Severe-6|CV / Virus stimulation, Condition and Cluster | 2.99e-04 | 195 | 30 | 3 | 69095c6ce2a7e763afa543c10d5710e0c3dda769 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 3.03e-04 | 196 | 30 | 3 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.08e-04 | 197 | 30 | 3 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-04 | 197 | 30 | 3 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.12e-04 | 198 | 30 | 3 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-04 | 198 | 30 | 3 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.17e-04 | 199 | 30 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.17e-04 | 199 | 30 | 3 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.17e-04 | 199 | 30 | 3 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.17e-04 | 199 | 30 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.22e-04 | 200 | 30 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.22e-04 | 200 | 30 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 4.18e-04 | 45 | 30 | 2 | 5488dced1d338166f3021509ebe8673e03995978 | |
| Computational | Neighborhood of RTN1 | 1.15e-04 | 52 | 20 | 3 | GNF2_RTN1 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.45e-06 | 179 | 30 | 5 | 4585_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.39e-06 | 188 | 30 | 5 | 6735_DN | |
| Drug | nocodazole; Up 200; 1uM; MCF7; HG-U133A | 5.24e-06 | 195 | 30 | 5 | 621_UP | |
| Disease | Bladder Neoplasm | 2.90e-07 | 140 | 30 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.00e-07 | 141 | 30 | 5 | C0005684 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 9.99e-07 | 2 | 30 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Carcinoma, Transitional Cell | 9.85e-06 | 41 | 30 | 3 | C0007138 | |
| Disease | prostate cancer (is_marker_for) | 1.85e-05 | 156 | 30 | 4 | DOID:10283 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 4.16e-05 | 66 | 30 | 3 | DOID:3459 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.75e-05 | 69 | 30 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | taurodeoxycholate measurement | 6.55e-05 | 12 | 30 | 2 | EFO_0010539 | |
| Disease | T-Cell Lymphoma | 1.19e-04 | 16 | 30 | 2 | C0079772 | |
| Disease | Squamous cell carcinoma of esophagus | 1.23e-04 | 95 | 30 | 3 | C0279626 | |
| Disease | Sezary Syndrome | 3.45e-04 | 27 | 30 | 2 | C0036920 | |
| Disease | Malignant neoplasm of breast | 6.43e-04 | 1074 | 30 | 6 | C0006142 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 9.63e-04 | 45 | 30 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | vital capacity | 1.33e-03 | 1236 | 30 | 6 | EFO_0004312 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.44e-03 | 55 | 30 | 2 | C0079744 | |
| Disease | cognitive function measurement | 2.83e-03 | 1434 | 30 | 6 | EFO_0008354 | |
| Disease | Cleft Palate | 3.08e-03 | 81 | 30 | 2 | C0008925 | |
| Disease | Prostatic Neoplasms | 3.35e-03 | 616 | 30 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.35e-03 | 616 | 30 | 4 | C0376358 | |
| Disease | Adenoid Cystic Carcinoma | 4.65e-03 | 100 | 30 | 2 | C0010606 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 5.13e-03 | 346 | 30 | 3 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Adenocarcinoma | 6.20e-03 | 116 | 30 | 2 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 6.20e-03 | 116 | 30 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 6.20e-03 | 116 | 30 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 6.20e-03 | 116 | 30 | 2 | C0205642 | |
| Disease | Carcinoma, Cribriform | 6.20e-03 | 116 | 30 | 2 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 6.20e-03 | 116 | 30 | 2 | C0205641 | |
| Disease | Squamous cell carcinoma | 7.06e-03 | 124 | 30 | 2 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MPPMTPMAPMGMNPP | 1956 | Q09472 | |
| PMAPMGMNPPPMTRG | 1961 | Q09472 | |
| GMPPAGTGMPMMPQQ | 841 | O60641 | |
| MLMMPPPPAAMGPPG | 666 | Q92997 | |
| PGMALPYNPMMVVMM | 671 | O14641 | |
| GTPMIPVPMSIMAPA | 36 | P49756 | |
| MPPQLETPRMMMTPP | 361 | Q96EV2 | |
| KMEIPGPMPPLIREM | 401 | P13631 | |
| LGMPPMVMSRFPFMG | 3116 | Q8NEZ4 | |
| PAMMMHGGPPTHPGM | 436 | O14770 | |
| ALGMMTGIPPITPMM | 66 | Q16206 | |
| TMTMACETPPGMSMP | 86 | Q9UBC0 | |
| NMPPVPHGMMPQMMP | 76 | O75400 | |
| AYQPGMVPAPMPMMP | 831 | Q96JP2 | |
| MVPAPMPMMPAMGTV | 836 | Q96JP2 | |
| MPMMPAMGTVPAMPA | 841 | Q96JP2 | |
| AMGTVPAMPAMVVPP | 846 | Q96JP2 | |
| SMLPMMLPGMAAVPQ | 2516 | Q8TD26 | |
| MMPGAPLQPVPMFSV | 106 | Q9NR56 | |
| GTVPMPMPMPMPSAN | 226 | P53990 | |
| APASGTMPMPLMSAM | 956 | Q8NET4 | |
| VPFMMPTMALPGLPA | 2446 | A2VEC9 | |
| PPMMRPPARPMMVPT | 136 | P09234 | |
| PPARPMMVPTRPGMT | 141 | P09234 | |
| PIAMQAGIPMGPMPA | 76 | Q9UMZ2 | |
| PMMAMLRGPKEWMLP | 631 | O14594 | |
| NMNPMPMSGMPMGPD | 1406 | Q9Y6Q9 | |
| PRMMSGRPAMDIPPI | 746 | Q9Y520 | |
| PPPMPPMNFDPRWMM | 711 | P48634 | |
| MAMLIPLMPLMPPPS | 631 | Q8IUH8 | |
| PNSIMGSMMPPPVGM | 306 | Q8WU79 | |
| MPNGPMPVPQMMNFG | 496 | A7XYQ1 | |
| PGMVPPMMPGMLMPA | 56 | Q6NWY9 | |
| PMMPGMLMPAVPVTA | 61 | Q6NWY9 | |
| MGMGVAGMPPFGMPP | 616 | Q15637 | |
| PMGTMPPSMCMKPQQ | 3381 | O14686 |